VERA
Vera Therapeutics Inc - Ordinary Shares - Class A

1,385
Mkt Cap
$2.94B
Volume
1.38M
52W High
$50.16
52W Low
$18.53
PE Ratio
-12.49
VERA Fundamentals
Price
$49.80
Prev Close
$46.02
Open
$45.93
50D MA
$31.98
Beta
1.04
Avg. Volume
1.75M
EPS (Annual)
-$2.75
P/B
7.98
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Vera Therapeutics (NASDAQ:VERA) Hits New 12-Month High - Here's Why
Vera Therapeutics (NASDAQ:VERA) Sets New 1-Year High - Time to Buy...
MarketBeat·9h ago
News Placeholder
More News
News Placeholder
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) have received a consensus rating of "Moderate Buy" from the thirteen brokerages that are currently covering the company...
MarketBeat·1d ago
News Placeholder
Soviero Asset Management LP Invests $707,000 in Vera Therapeutics, Inc. $VERA
Soviero Asset Management LP acquired a new stake in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund...
MarketBeat·3d ago
News Placeholder
188,422 Shares in Vera Therapeutics, Inc. $VERA Acquired by Norges Bank
Norges Bank purchased a new stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional...
MarketBeat·3d ago
News Placeholder
Vera Therapeutics (NASDAQ:VERA) Shares Gap Down - What's Next?
Vera Therapeutics (NASDAQ:VERA) Shares Gap Down - Should You Sell...
MarketBeat·4d ago
News Placeholder
Bollard Group LLC Takes $1.51 Million Position in Vera Therapeutics, Inc. $VERA
Bollard Group LLC acquired a new stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·6d ago
News Placeholder
Vera Therapeutics (NASDAQ:VERA) Price Target Raised to $73.00
TD Cowen upped their target price on Vera Therapeutics from $60.00 to $73.00 and gave the company a "buy" rating in a report on Friday...
MarketBeat·7d ago
News Placeholder
Schroder Investment Management Group Reduces Stock Position in Vera Therapeutics, Inc. $VERA
Schroder Investment Management Group lessened its position in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 18.8% during the second quarter, according to the company in its most recent...
MarketBeat·8d ago
News Placeholder
XTX Topco Ltd Grows Position in Vera Therapeutics, Inc. $VERA
XTX Topco Ltd lifted its position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 451.8% in the second quarter, according to its most recent 13F filing with the SEC. The firm...
MarketBeat·13d ago
News Placeholder
Vera Therapeutics (NASDAQ:VERA) Stock Price Up 11.8% - Should You Buy?
Vera Therapeutics (NASDAQ:VERA) Stock Price Up 11.8% - Time to Buy...
MarketBeat·16d ago

Latest VERA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.